image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
Filing Date
March 17, 2022
Document Date
December 31, 2021
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC